Drug intelligence / Profile preview

10-hydroxycamptothecin

Development stage
Unknown
Lead developer
3R Pharma Consulting
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Administration
Intravenous
01

Overview

10-hydroxycamptothecin is a natural plant alkaloid derived from the *Camptotheca acuminata* tree, known for its potent antitumor activity. It acts as a DNA topoisomerase I inhibitor, interfering with DNA replication and transcription, which leads to cell cycle arrest and apoptosis in cancer cells. The compound has demonstrated effectiveness against various cancers, including colorectal and ovarian cancers. Its clinical application has been limited by poor water solubility and instability of its lactone ring; however, advances in nanomedicine are being explored to improve its delivery and efficacy. 10-hydroxycamptothecin is currently under investigation for use in myelodysplastic syndrome (MDS) and other malignancies.

Brand names
Hydroxycamptothecin for injection
Other names
(S)-10-hydroxycamptothecinHCPT
02

Targets

TOP1 (DNA Topoisomerase I)

Beyond the preview

Go deeper on 10-hydroxycamptothecin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 10-hydroxycamptothecin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call